Mandate

VINGE ADVISES INDUSTRIFONDEN IN CONNECTION WITH THE FINANCING OF HASSELBLAD’S NEW CAMERAS

December 11, 2013

Industrifonden has provided financing to the camera maker, Hasselblad, in the form of a loan of approximately SEK 78 million with detachable options. The funds will be used for the launch of Hasselblad’s new series of cameras and for renewal of the existing range of cameras.

The new cameras will be available on the market shortly and the first two models, i.e. Lunar and Stellar, were launched recently. Since they are intended for amateur photographers, they are in a lower price and performance segment compared to Hasselblad’s traditional range of products, which are directed toward professional photographers.

Hasselblad’s current owner, the German-Swiss private equity firm, Vorndran Mannheims Capital, has made significant contributions in the form of renewal and greater degree of frequency of change of models in the existing H-system, where H5D was launched at the beginning of 2013.

Hasselblad’s production and R&D divisions are now based in Gothenburg where the company has doubled its production capacity and has recruited new personnel. Hasselblad is thus once again primarily a Swedish company.

Vinge’s team consisted of partner Johan Larsson and associate Lisa Antman.   

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025